Lancet The Journal

Overview
Identity
View All

publication venue for

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study. 408:521-531. 2026
Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990¿2023: a systematic analysis for the Global Burden of Disease Study 2023. 407:31-52. 2026
Prevalence of sexual violence against children and age at first exposure: a global analysis by location, age, and sex (1990¿2023). 405:1817-1836. 2025
Relieve the suffering: palliative care for the next decade. 405:1802-1804. 2025
The Lancet Breast Cancer Commission. 403:1895-1950. 2024
Missing voices from Latin America in the O'Neill¿Lancet Commission. 403:436. 2024
Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption. 402:731-746. 2023
Latin America needs evidence-supported health-care policies. 400:1680. 2022
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). 398:1713-1725. 2021
SARS-CoV-2 serosurveys in low-income and middle-income countries. 397:353-355. 2021
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. 388:2997-3005. 2016